← Open Payments lookup

GABRIELA GONZALEZ: Open Payments

NPI 1457815797 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,977 in 88 payments from 16 companies in 2025. Trend: 2023 $494 · 2024 $2,246 · 2025 $1,977

Food & beverage: $1,977
CompanyPaymentsAmount
ABBVIE INC.33$566
Madrigal Pharmaceuticals11$350
Salix Pharmaceuticals, a division of Bausch Health US, LLC13$219
Takeda Pharmaceuticals U.S.A., Inc.6$208
Phathom Pharmaceuticals, Inc.4$164
GENZYME CORPORATION3$109
Gilead Sciences, Inc.4$89
Janssen Biotech, Inc.2$48
PFIZER INC.3$44
Ipsen Biopharmaceuticals, Inc2$36

Products named: REZDIFFRA, RINVOQ, XIFAXAN, MAVYRET, VOQUEZNA, LINZESS, DUPIXENT, ENTYVIO.

Industry payments across TX — which companies pay providers there.